Lakewood-Amedex Biotherapeutics Inc. (LABT)

Lakewood-Amedex Biotherapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

LABT Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Debt / Equity Ratio	-1.33	0.67	0.13
Debt / EBITDA Ratio	-0.43	-0.06	-0.07
Debt / FCF Ratio	-0.75	-0.05	-0.08
Quick Ratio	0.30	1.36	3.10
Return on Equity (ROE)	320.74%	-1185.37%	-181.69%
Return on Assets (ROA)	-	-453.53%	-120.13%
Return on Capital (ROIC)	-927.96%	-590.03%	-168.12%
Return on Capital Employed (ROCE)	184.72%	-876.04%	-178.67%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).